Document Detail

Prior aspirin use and outcomes in acute coronary syndromes.
MedLine Citation:
PMID:  20946994     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: The purpose of this study was to determine whether patients taking aspirin before an acute coronary syndrome (ACS) are at higher risk of recurrent events or mortality.
BACKGROUND: Controversy exists whether prior aspirin use is an independent predictor of worse outcomes in patients who experience an ACS.
METHODS: We evaluated 66,443 ACS patients from a merged database of previous Thrombolysis in Myocardial Infarction trials. We evaluated the differences in ACS type, total mortality, and the composite end point of death, myocardial infarction (MI), recurrent ischemia, or stroke between prior aspirin and nonprior aspirin users. We used multivariate analysis to control for differences in baseline characteristics.
RESULTS: Prior aspirin users (n = 17,839) were older (63 years vs. 59 years) and had more coronary risk factors and evidence of coronary artery disease (MI, angina, prior intervention) than nonprior aspirin users (n = 48,604) (all p < 0.0001). Prior aspirin use was associated with less severe types of ACS at presentation (e.g., unstable angina > non-ST-segment elevation MI > ST-segment elevation MI) than their nonaspirin user counterparts (p < 0.0001). After multivariate analysis, there was no difference in total mortality between prior aspirin users and nonaspirin users at day 30 (odds ratio [OR]: 1.01; 95% confidence interval [CI]: 0.90 to 1.13) or by the last follow-up visit (mean 328 days) (hazard ratio: 1.03; 95% CI: 0.95 to 1.11). Prior aspirin use was modestly associated with recurrent MI (OR: 1.26; 95% CI: 1.12 to 1.43) and the composite end point (OR: 1.16; 95% CI: 1.08 to 1.24).
CONCLUSIONS: Prior aspirin use was associated with more comorbidities and coronary disease and a higher risk of recurrent MI, but not mortality. As such, it should best be considered a marker of a patient population at high risk for recurrent adverse events after ACS.
Jonathan D Rich; Christopher P Cannon; Sabina A Murphy; Jie Qin; Robert P Giugliano; Eugene Braunwald
Related Documents :
15561064 - Cardiopulmonary bypass with bivalirudin in type ii heparin-induced thrombocytopenia.
7336144 - Heparin levels and activated clotting time (act) during open heart surgery.
9737474 - Clinical potential of antithrombotic drugs in coronary syndromes.
12088354 - Optimizing glycoprotein iib/iiia inhibition: lessons from recent randomized controlled ...
24034094 - Gender disparity in early death after st-elevation myocardial infarction.
6851574 - Solar activity and myocardial infarction.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  56     ISSN:  1558-3597     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-15     Completed Date:  2010-11-01     Revised Date:  2011-06-01    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1376-85     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Section of Cardiology, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Coronary Syndrome / mortality,  physiopathology*,  radiography
Aspirin / administration & dosage,  adverse effects*
Coronary Angiography
Coronary Disease / therapy
Kaplan-Meier Estimate
Middle Aged
Platelet Aggregation Inhibitors / administration & dosage,  adverse effects*
Risk Factors
Survival Rate
Reg. No./Substance:
0/Platelet Aggregation Inhibitors; 50-78-2/Aspirin
Comment In:
J Am Coll Cardiol. 2011 Apr 19;57(16):1715; author reply 1715-6   [PMID:  21492774 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Long-Term Outcomes After Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main C...
Next Document:  Optical mapping of the isolated coronary-perfused human sinus node.